Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

3.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
3.8K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.2K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.2K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.9K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.9K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.0K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.1K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toward international collaboration in allergy care - WAO White Book on Allergy 2026 - Introduction.

The World Allergy Organization journal·2026
Same author

Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement.

European heart journal·2026
Same author

The 2025 WAO Guidelines for the classification, diagnosis, and treatment of hereditary angioedema, with consideration of worldwide disparities.

The World Allergy Organization journal·2026
Same author

Toward equitable and evidence-based care in Hereditary Angioedema: Time for inclusive global guidelines.

The World Allergy Organization journal·2026
Same author

Global survey of genetic testing methods for familial hypercholesterolemia. A study and recommendations from the EAS FHSC registry.

European journal of preventive cardiology·2026
Same author

The Genetics of Iron Metabolism on Biochemical and Hematological Phenotypes of Heart Failure.

International journal of molecular sciences·2026

Related Experiment Video

Updated: Dec 11, 2025

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.5K

Metabolic Dysfunction and Asthma: Current Perspectives.

Helena Pite1,2, Laura Aguiar1, Judit Morello2

  • 1Allergy Center, CUF Infante Santo Hospital/CUF Descobertas Hospital, Lisbon, Portugal.

Journal of Asthma and Allergy
|August 18, 2020
PubMed
Summary
This summary is machine-generated.

Metabolic dysfunction, including obesity, is linked to asthma severity and poor treatment response. Understanding these links and other metabolic conditions is key for effective asthma management and personalized treatment strategies.

Keywords:
asthmadietinflammationmetabolicmetabolomicsobesity

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.3K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.4K

Related Experiment Videos

Last Updated: Dec 11, 2025

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes
08:30

Intraperitoneal Glucose Tolerance Test, Measurement of Lung Function, and Fixation of the Lung to Study the Impact of Obesity and Impaired Metabolism on Pulmonary Outcomes

Published on: March 15, 2018

14.5K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.3K
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

11.4K

Area of Science:

  • Pulmonary Medicine
  • Metabolic Disorders
  • Immunology

Background:

  • Metabolic dysfunction is increasingly recognized as a significant factor in the pathophysiology of pulmonary diseases, particularly asthma.
  • Obesity is a well-established risk factor for asthma, often leading to a more severe and refractory disease with a poorer response to standard treatments.
  • Emerging research, including metabolomics, is revealing molecular links between obesity and asthma phenotypes.

Purpose of the Study:

  • To review current understanding of metabolic dysfunction in asthma, encompassing obesity-related and other independent metabolic conditions.
  • To discuss the role of current pharmacological therapies and lifestyle interventions in managing asthma with metabolic comorbidities.
  • To highlight novel insights from metabolomics studies in asthma pathogenesis.

Main Methods:

  • Literature review of current research on metabolic dysfunction and asthma.
  • Analysis of epidemiological, clinical, and molecular data, including metabolomics studies.
  • Evaluation of current therapeutic strategies, both pharmacologic and non-pharmacologic.

Main Results:

  • Metabolic dysregulation, including hyperinsulinemia, dyslipidemia, and hypertension, is independently associated with asthma, even in non-obese individuals.
  • Metabolomics studies identify altered metabolic pathways in asthma, involving oxidative stress, systemic inflammation, and the gut microbiota.
  • Certain pharmacological treatments are effective regardless of body mass index, and lifestyle interventions like weight reduction offer significant benefits.

Conclusions:

  • Metabolic dysfunction is a critical, multifaceted aspect of asthma pathophysiology requiring integrated management.
  • Personalized medicine approaches, considering environmental factors and a holistic patient view, are essential for optimizing asthma treatment.
  • Further research is needed to elucidate the complex interplay between environmental factors, metabolic dysfunction, and asthma development.